Attached files
Exhibit 32.2
Certification of Chief Financial Officer
Pursuant to 18 U.S.C Section 1350,
As Adopted Pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002
Not Filed Pursuant to the Securities Exchange Act of 1934
In connection with the Annual Report
of Ohr Pharmaceutical, Inc. (the “Company” ) on Form 10-K for
the period ending September 30, 2014, as filed with the Securities and Exchange Commission on the date hereof (the “Report”
), I, Sam Backenroth , Chief Financial Officer, of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant
to Section 906 of the Sarbanes-Oxley Act of 2002, that:
1. | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and | |
2. | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
Dated: December 22, 2014
/s/ Sam Backenroth | |
Name: Sam Backenroth | |
Title: Chief Financial Officer |